Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Biopsy-proven newly diagnosed carcinoma cervix Stage IB, IIA, IIB, IIIB; without lower one third of vagina involvement. ECOG 0-2 Age less than 70 years No major life threatening complications Willingness to comply with study procedures and provide informed consent
Exclusion criteria
Exclusion criteria: ECOG 3 or more Prior pelvic radiotherapy Uncontrolled diabetes and hypertension Prior history of DVT/ Pulmonary embolism Pregnancy or lactating women Lower one-third involvement of vagina in any stage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the locoregional control up to 6 months post radiotherapy in patients with cervical cancer.Timepoint: 6 months after treatment completion | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate early acute and acute toxicities (less than 3months, and less than 6months respectively) associated using CTCAE Version 5.0 toxicity criteriaTimepoint: 3 months, 6 months;To evaluate late toxicities (more than 6months) associated with the therapeutic pelvic irradiationTimepoint: 1 year | — |
Countries
India
Contacts
Jawaharlal Institute of Postgraduate Medical Education and Research